0.00Open0.00Pre Close0 Volume0 Open Interest17.00Strike Price0.00Turnover91.80%IV-32.19%PremiumNov 15, 2024Expiry Date4.14Intrinsic Value100Multiplier9DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9736Delta0.0422Gamma3.10Leverage Ratio-0.0046Theta-0.0019Rho-3.02Eff Leverage0.0012Vega
Elanco Animal Health Stock Discussion
3 mins ago
Elanco Receives FDA Approval for Credelio Quattro™ (Lotilaner, Moxidectin, Praziquantel, and Pyrantel Chewable Tablets), the Broadest(I) Canine Oral Parasiticide Protection in a Single Monthly Dose
No comment yet